Tweetovi

Blokirali ste korisnika/cu @doctorpemm

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @doctorpemm

  1. Prikvačeni tweet
    24. tra 2019.

    👉👉👉Hot off the presses Our group’s new paper just out in ⁦⁩ !! ➡️ (SL-401) in Blastic Plasmacytoid Dendritic-Cell Neoplasm | | ⁦⁩ ⁦⁩ Konopleva ⁦⁩ ⁦

    Poništi
  2. proslijedio/la je Tweet

    Amazing lecture on by 👏🏻🤓 Very impressed by your enthusiastic and thoughtful way of presenting! 😁 And by the outstanding work to lead the approval of tagraxofusp, the first drug approved for this rare disease! 👍🏼🏆

    Poništi
  3. proslijedio/la je Tweet
    prije 10 sati

    Thank you so much Dr. Pemmeraju! We are very fortunate to have great teachers, mentors, clinicians and researchers like you at the heart of our fellowship program

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    1. lip 2019.

    I am absolutely grateful to be part of an outstanding fellowship family , with top-notch leadership who motivate us to be the best versions of ourselves, phenomenal mentors and the best cofellows one can ask for!

    Prikaži ovu nit
    Poništi
  5. proslijedio/la je Tweet

    One perk as president - I get sneak 👀 of our annual report!! Very proud of the 👍👏🥳😎🥇🏆 accomplishments - 🙏🙏🙏 to our volunteers, members and staff

    Poništi
  6. proslijedio/la je Tweet

    Characteristically energetic lecture by from on this often misunderstood disease. IKZF1 inactivation and BCL-2 dependence inform this HCVAD + Ven backbone.

    Poništi
  7. proslijedio/la je Tweet
    prije 12 sati
    Poništi
  8. Special shout out & 🙏 to Director of Fellowship Education Dr GGM & Co-Director for inviting me to speak at their successful & innovative Leukemia Fellows Lecture Series.Honored to present 101 to such a highly motivated & engaged group !

    , , i još njih 5
    Poništi
  9. ➡️➡️➡️Hot off the presses! Use of CAR-Transduced Natural Killer Cells in -Positive Lymphoid Tumors | & {Liu E/Rezvani K et al Feb 6, 2020}

    Poništi
  10. Very nice paper from Dr Bastidas Torres et al (The Netherlands 🇳🇱 + Italy 🇮🇹 collaboration) Whole‐genome analysis uncovers recurrent inactivation&aberrant cell adhesion in {Genes, Chromosomes and Cancer 2020 Wiley Online Library}

    Poništi
  11. proslijedio/la je Tweet

    New blastic plasmacytoid dendritic cell neoplasm () treatment improves outlook for many patients [Jun 4, 2019] by Staff Cancerwise cc

    Poništi
  12. Wonderful talk by Dr Nitin Jain at Grand Rounds this AM. Updates in CLL ➡️ including nice teaching slide showing a sampling of frontline phase 3 clinical trials in CLL field.

    Poništi
  13. proslijedio/la je Tweet
    4. velj

    I am delighted to call attention to our partnership with MD Anderson that resulted in an IRB approved survey of 1,000 patients living with an MPN, myeloproliferative neoplasm. This video explains:

    Poništi
  14. proslijedio/la je Tweet

    When I started fellowship training , my friend told me: You need a passing game (big research papers, RCTs), but also a running game (case reports, chart reviews, letters, reviews). Do both. Become good at it. This strategy has served me well.

    Poništi
  15. 5. velj

    Another spectacular to appreciate this evening. A place of a moment to stop and appreciate the moment |

    Poništi
  16. proslijedio/la je Tweet
    4. velj

    Register for the latest clinical advancements in hematologic malignancies in a debate-driven, 2-day conference chaired by , and !

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet
    4. velj

    Take a sneak peek into IACH prelimanry scientific program and join us at this exciting innovative meeting:

    Poništi
  18. proslijedio/la je Tweet
    2. velj

    Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

    Poništi
  19. proslijedio/la je Tweet
    3. velj
    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet

    Thanks to a Phase II clinical trial led by our Dr. Loretta Nastoupil, Kelly Hale achieved remission just three months after being diagnosed with B-cell :

    Poništi
  21. proslijedio/la je Tweet
    1. velj

    Spent my 12th birthday in a transitional orphanage in Spent 6 years in a broken system Yet some people still believed in me Yet some people cared Yet God was good Now I get to serve suffering patients with cancer as a and See the unseen

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·